Evaluation of prognosis of treatment with catheter ablation for patients with arrhythmia-induced cardiomyopathy caused by atrial fibrillatio
Not Applicable
Recruiting
- Conditions
- Atrial fibrillation and heart failure
- Registration Number
- JPRN-UMIN000050391
- Lead Sponsor
- niversity of Fukui
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
patients with severe old myocardial infarction
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiovascular death or hospitalization due to heart failure. Moreover, the composite endpoint was defined as cardiovascular death or hospitalization due to heart failure.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie arrhythmia-induced cardiomyopathy in atrial fibrillation patients undergoing catheter ablation?
How does catheter ablation compare to standard-of-care treatments for heart failure in atrial fibrillation-induced cardiomyopathy?
Which biomarkers are associated with improved prognosis following catheter ablation for AIC caused by atrial fibrillation?
What are the potential adverse events of catheter ablation in patients with arrhythmia-induced cardiomyopathy and atrial fibrillation?
Are there combination therapies or alternative approaches that enhance catheter ablation outcomes for AIC in atrial fibrillation patients?